CNS market to surpass $80 bn in 2025, driven by MS and psychiatric drug innovation: GlobalData
The revival of CNS drug development is being fueled by advancements in neuroimmunology and neurodegeneration, moving beyond…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Cell and gene therapy market set to grow at 44% CAGR through 2030: GlobalData
GlobalData’s report reveals that CGT market for GI disorders, as a standalone therapy area, is expected to increase from $47…
Cadila Pharma launches Cadilose, a lactulose solution for constipation and hepatic encephalopathy
Cadilose is a disaccharide-based osmotic laxative, synthesised from galactose and fructose, which increases water retention in the…
Blood cancers dominate CAR-T pipeline: GlobalData
According to GlobalData’s Drugs Database, blood cancers account for over half of all CAR-Ts in the active pipeline* and make up…
Lilly launches Mounjaro (tirzepatide), offers new treatment option for obesity and type 2 diabetes
Phase 3 SURPASS programme demonstrated that Mounjaro, whether used alone or with other diabetes medications, reduced A1C by up to…
NHS approval of endometriosis therapy Ryeqo enhances patient care: GlobalData
GlobalData’s report reveals that the endometriosis market size across the seven major markets is expected to achieve a compound…
USV launches Xenia: Empagliflozin and its combinations for diabetes care in India
With the loss of exclusivity, Empagliflozin and its combinations are now available at one-fifth the cost, enhancing affordability
Glenmark USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC)
It compares to the active ingredient in MiraLAX Powder for Solution, 17 grams of Bayer HealthCare
India’s CRDMO sector growth potential at $22 – $25 bn by 2035: BCG-IPSO Report
Report states that India’s CRDMO sector is poised for rapid growth with strong fundamentals and global realignments, focusing on…
Funding in pharma plummets by 85 per cent in Feb 2025
As per data provided by Tracxn, the decline in investment activity makes February 2025 one of the lowest-funded months in the past…
Zydus launches ANVIMO for prevention of CMV
Zydus has reduced the cost of Letermovir by 91 per cent of the innovator price. ANVIMO will be available in dosages of 240 mg and…
Venus Remedies gains global marketing authorisation for Sugammadex from the Philippines
The global Sugammadex market, valued at approximately 1.53 billion in 2023, is projected to grow at a CAGR of 8.5 per cent,…
Glenmark USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose…
Glenmark acquired the ANDA for Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials from Aspen Pharma USA
Fragile X syndrome market to quadruple to $111.9 million in US and Germany by 2030, forecasts…
Targeted therapies poised to transform Fragile X syndrome market with 4X growth by 2030
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
Novel therapies and regulatory shifts drive growth in the Duchenne muscular dystrophy market, with exon-skipping therapies leading…
Obesity market to reach $173.5 billion sales in 7MM by 2031, forecasts GlobalData
Growing patient awareness and emerging therapies drive obesity drug market expansion across the US, Europe, and Japan
Evolution and commercialisation of cell and gene therapies
Satyen Sanghavi, Founder & CSO, Regrow Biosciences traces the evolution of cell and gene therapies, highlighting global…
IXP launches Lifesciences catalyst fund for early-stage investments
Fund targets INR 200 crore corpus with focus on biotech, pharma, and medical
India Ratings and Research maintains Neutral Outlook for pharmaceuticals sector in FY26
Revenue growth projected at 9 % -10 % year-on-year; operating margins expected to remain stable
Pharma M&A and venture capital deals reach $33.7 billion in Jan 2025
Johnson & Johnson, Eli Lilly, and Gilead Sciences lead M&A activity; Venture capital investments increase by 62.1 per cent…